HUTCHMED (China) Limited (HCM)
NASDAQ: HCM · IEX Real-Time Price · USD
18.94
-0.25 (-1.30%)
At close: Jul 19, 2024, 4:00 PM
19.03
+0.09 (0.48%)
Pre-market: Jul 20, 2024, 9:29 AM EDT

HUTCHMED (China) Revenue

In the year 2023, HUTCHMED (China) had annual revenue of $838.00M with 96.52% growth.

Revenue (ttm)
$838.00M
Revenue Growth
+135.31%
P/S Ratio
3.94
Revenue / Employee
$421,529
Employees
1,988
Market Cap
3.30B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023838.00M411.59M96.52%
Dec 31, 2022426.41M70.28M19.73%
Dec 31, 2021356.13M128.15M56.21%
Dec 31, 2020227.98M23.09M11.27%
Dec 31, 2019204.89M-9.22M-4.31%
Dec 31, 2018214.11M-27.09M-11.23%
Dec 31, 2017241.20M25.12M11.63%
Dec 31, 2016216.08M37.88M21.25%
Dec 31, 2015178.20M90.87M104.06%
Dec 31, 201487.33M50.78M138.95%
Dec 31, 201336.55M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Amedisys 2.25B
GoodRx Holdings 764.16M
Inari Medical 520.66M
Axonics 387.14M
TG Therapeutics 289.33M
PROCEPT BioRobotics 156.33M
Arcellx 131.66M
Arrowhead Pharmaceuticals 35.47M
Revenue Rankings